Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSU6162 for Residual Symptoms After Stroke
NCT04127669Phase 2Completed
- Sponsor
- Arvid Carlsson Research AB
- Start
- Mar 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OSU-6162 in stroke sequelae, sponsored by Arvid Carlsson Research AB. Started Mar 2017; status: completed.
02
Drugs
OSU-6162
03
Conditions
stroke sequelae
Beyond the preview
Go deeper on NCT04127669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04127669.